Navigation

News

Your contact person

Manager PR & Communications Jan Phillip Denkers

Filter reset
Onco AI-Med meeting at Indivumed: Dr. David Kerr, Nils Schumacher, Prof. Gerry Melino, Nina Gabelia, Dr. John Marshall, Dr. Takayuki Yoshino, Prof. Hartmut Juhl, Dr. Sun Young Rha, Dr. Jesus Garcia-Foncillas, Dr. Carlos Sampaio and Dr. David Gallagher (fr
Onco AI-Med meeting at Indivumed: Dr. David Kerr, Nils Schumacher, Prof. Gerry Melino, Nina Gabelia, Dr. John Marshall, Dr. Takayuki Yoshino, Prof. Hartmut Juhl, Dr. Sun Young Rha, Dr. Jesus Garcia-Foncillas, Dr. Carlos Sampaio and Dr. David Gallagher (from left to right) (Picture: Indivumed)

Indivumed Hosts Onco AI-Med Annual Board Meeting in Hamburg

Indivumed Therapeutics (“Indivumed”) welcomed members of the Oncology Alliance For Individualized Medicine (“Onco AI-Med”) to its global headquarters in Hamburg, ...

Read more …
Reach out to artificial intelligence and improve your career opportunities in robotics, medical technology and many other fields!
You want to become an "AI Master"? Then the University of Lübeck has the right offer for you! (Image: @ Possessed Photography/unsplash)

AI Master - Online advanced study at the University of Lübeck

The University of Lübeck is offering a new online master's program in artificial intelligence as advanced study for technical professionals who ...

Read more …
FUSE-AI starts global sales at the G20 Digital Innovation Network in Indonesia. (Image: © FUSE_AI)

FUSE-AI takes off

The G20 Digital Innovation Network is a high-level forum for sharing knowledge, fostering discussion and building partnerships between global innovation players. It aims to serve ...

Read more …
BreastIHC is a plug-and-play solution that enables pathology laboratories to instantaneously detect, classify and quantify breast cancer cells stained with immuno-histochemistry. (Picture: ©Mindpeak GmbH)

Large US laboratory relies on Mindpeak technology

Hamburg, Germany, based Mindpeak and Spokane, WA, based Gestalt Diagnostics have achieved a major success on their way to improve patient care with ...

Read more …
Indivumed is using nRavel™ for target discovery and drug development programs. (Picture: ©Jackie Niam/stock.adobe.com)

Indivumed Launches the nRavel AI Platform

Indivumed GmbH (“Indivumed”) today announced the launch of nRavel™, a unique AI discovery platform for oncology and precision medicine. The platform combines ...

Read more …
Job board